Skip to main content
. 2018 Aug 8;9(12):3153–3165. doi: 10.1021/acschemneuro.8b00337

Table 1. Summary of K2P Response to BL-1249a.

background mutant EC50 (μM) n (≥)
K2P2.1(TREK-1)   5.5 ± 1.2 3
  K2P2.1(TREK-1)GGG 19 ± 1 3
  K2P2.1(TREK-1)Δ322 26 ± 8b 2
  K2P2.1(TREK-1)Δ308 35 ± 8b 2
  TREK-1/AAK_T 7.7 ± 0.6 2
  TREK-1/AAK M4-C 19 ± 3 3
  TREK-1/AAK M3-C 28 ± 2 3
  TREK-1/AAK M2-C 39 ± 9 3
  TREK-1/TRAAK M2 26 ± 8 3
  F172M 15 ± 2 3
  F185L 27 ± 5 3
K2P10.1(TREK-2)   8.0 ± 0.8 3
K2P4.1(TRAAK)   48 ± 10b 3
  TRAAK/EK-1_T 23 ± 4 2
  TRAAK/EK-1 M4-C 45 ± 2 3
  TRAAK/EK-1 M3-C 18 ± 2 3
  TRAAK/EK-1 M2-C 28 ± 5 3
  TRAAK/TREK-1 M2 43 ± 11 3
  M134F 58 ± 34b 2
  L147F 27 ± 4 3
a

Data derived from at least two independent experiments with each data point averaged from at least three oocytes.

b

Experiments where complete saturation of the response could not be reached due to BL-1249 solubility limits. For these cases, fits were imposed with an upper boundary of 15 (fold activation, I/I0) to estimate EC50 and error.